Trials / Sponsors / Orbus Therapeutics, Inc.
Orbus Therapeutics, Inc.
Industry · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma Glioblastoma, IDH-wildtype, Glioblastoma, Glioblastoma Multiforme | Phase 1 | 2023-07-24 |
| Unknown | Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients Anaplastic Astrocytoma, Recurrent Anaplastic Astrocytoma | Phase 3 | 2016-07-01 |